REQUEST A DEMO

Related to ‘DOJ’

Reducing FCPA Risks and Achieving Third-Party Compliance in the Pharmaceutical & Medical Devices Industries

Wednesday, August 24th, 2016
Read More

FCPA Third-Party Risk and Compliance for Pharmaceutical Companies

Thursday, May 19th, 2016
Read More

Beyond Dodd-Frank: Reducing Regulatory Risks

Monday, August 29th, 2016
Read More

Global 2000 Companies Face Increasing Regulatory Burdens and Complexity

Wednesday, August 31st, 2016
Read More

From FCPA to Reputation Risk: The Importance of Internal Controls

Tuesday, October 2nd, 2018
Read More

Reducing Regulatory Risks & Achieving Third-Party Compliance in Mining

Wednesday, October 19th, 2016
Read More

The DOJ’s “Evaluation of Corporate Compliance Programs”

Tuesday, February 21st, 2017
Read More

Speaking of Risk: Pharmaceutical Companies and Third Party Promotions

Tuesday, March 7th, 2017
Read More

Five Key Trends in ABAC Enforcement Demand A Strategic Response From Companies

Tuesday, February 19th, 2019
Read More
Subscribe to Blog Updates